Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality Shanghai Sixth People's Hospital, Shanghai, Shanghai Municipality Shanghai GoBroad Caner Hospital China Pharmaceutical University, Shanghai, Shanghai Municipality Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi